XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:      
Net loss   $ (34,081) $ (53,819)
Adjustments to reconcile net loss to net cash from operating activities:      
Stock-based compensation expense   7,304 8,055
Change in fair value of derivative liability - warrants $ (2,722) (2,722)  
Impairment of prepaid manufacturing services 4,508 4,508  
Non-cash interest expense   308 392
Depreciation and amortization expense   3,181 4,205
Non-cash manufacturing expense   462  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets   2,949 (651)
Prepaid manufacturing services   12  
Operating right-of-use assets   1,003 745
Accounts payable   175 206
Accrued expenses   (1,725) 1,118
Deferred revenue   (24,970) (11,953)
Operating lease liabilities   (1,962) (920)
Net cash used in operating activities   (45,558) (52,622)
Cash flows from investing activities:      
Purchases of property and equipment   (362) (2,913)
Net cash used in investing activities   (362) (2,913)
Cash flows from financing activities:      
Proceeds from exercise of common stock options     3,523
Net cash received from Employee Stock Purchase Program (ESPP)   126  
Proceeds from issuance of common stock, net of issuance costs   20,618 61,681
Net cash provided by financing activities   20,744 65,204
Net (decrease) increase in cash, cash equivalents and restricted cash   (25,176) 9,669
Cash, cash equivalents and restricted cash, beginning of period   81,108 93,085
Cash, cash equivalents and restricted cash, end of period 55,932 55,932 102,754
Supplemental disclosures:      
Cash paid for interest   1,696 1,713
Non-cash investing and financing activities:      
Purchases of property and equipment included in accounts payable and accrued expenses   28 388
Offering costs included in accrued expenses   267  
Issuance of derivative liability - warrants   8,150  
Reconciliation to amounts within the consolidated balance sheets      
Cash and cash equivalents 51,762 51,762 98,584
Restricted cash 4,170 4,170 4,170
Cash, cash equivalents and restricted cash at end of period $ 55,932 $ 55,932 $ 102,754